VIDEOS

		Iridex New Sweep Management Software for MicroPulse TLT
		MicroPulse transscleral laser therapy aims to increase outflow to reduce IOP – Ye Elaine Wang, MD
		Add MicroPulse TLT to Your Glaucoma Toolkit - Ye Elaine Wang, MD
		MicroPulse TLT for Glaucoma Management in a Comprehensive Practice - Shahed Y Ghoghawala, MD
		The Best Part of MicroPulse TLT in a Tertiary Practice - Larissa Camejo, MD
		Advantages of MicroPulse P3 Cyclophotocoagulation
		Treating Glaucoma with the Cyclo G6 Laser - Long-Term Results
		Webinar with Dr. Nathan Radcliffe: Optimizing MicroPulse TSCPC for Multiple Glaucoma Types
		Webinar with Dr. Brian Jerkins: The Role of MicroPulse TSCPC for Glaucoma
		Dr. Takashi Fujishiro, MD talks about MicroPulse® TSCPC by Cyclo G6
		Dr. Nathan Radcliffe Discusses Experience with Cyclo G6 Laser
		Testimonial Dr Vital Paulino Costa Spanish
		Treating Glaucoma With MicroPulse Laser Therapy
		MicroPulse P3 Procedure for Glaucoma: Beyond Late Stage
		MicroPulse CPC Glaucoma Treatment and Patient’s Profiles
		Updates from the MicroPulse Aqueous Dynamics Study in Early or Moderate POAG
		IRIDEX MicroPulse ESCRS 2018 Symposium Q&A
		IRIDEX at the American Academy of Ophthalmology 2018
		Treating Glaucoma with the Cyclo G6 Laser - Long-Term Results
		Glaucoma Laser Treatment Now Available in Russia - Cyclo G6 Glaucoma Laser
		Cyclo G6™ Glaucoma Laser, an Alternative to Stents for Glaucoma - Dr. Rolando Toyos
		Laser-Assisted, Non-incisional Glaucoma Therapy
		Glaucoma Treatment With MicroPulse Therapy The award-winning series, Innovations with Ed Begley Jr., featured IRIDEX MicroPulse therapy for glaucoma on CNBC. In this episode, three top glaucoma specialists share what it is and how it works, and three glaucoma patients share how MicroPulse therapy has helped them to control glaucoma.
		Effect of Transscleral Diode Cyclophotocoagulation AGS The effect of Transscleral Diode Cyclophotocoagulation using MicroPulse versus Continuous Wave on Ciliary Body observed in Miyaki Apple View. John A. Moran Eye Center University of Utah. Do you ever wonder what CPC looks like inside the eye?
		IRIDEX AAO Dr Sieminski Dr. Sandra Sieminski talks about MicroPulse ® Technology for Glaucoma. Listen along as Dr. Sieminski shares results from a 6 month study on patients treated with the Cyclo G6 ™ Glaucoma Laser System.
		EGS Symposium: MicroPulse Therapy for Glaucoma Treatment Dr. Ziad Khoueir (Lebanon), Dr. Ronald de Crom (The Netherlands), Dr. Marc Toeteberg (Switzerland), and Dr. Karin Roswitha Pillunat (Germany) share how they are successfully treating multiple cases of glaucoma with the Cyclo G6 Glaucoma Laser and MicroPulse Technology at the European Glaucoma Society (EGS) congress in Florence, Italy.
		Latest Data on MicroPulse Cyclophotocoagulation In this interview from AGS 2017, Dr. Jonathan Myers discusses MicroPulse. At the meeting, the 10 posters on the MicroPulse showed good pressure reduction and success rates ranging from 50% to 80%.
		Cyclophotocoagulation with the CYCLO G6 laser EyeWorld Interviews Dr. Shan Lin at AAO about his experience treating glaucoma with the CYCLO G6 Glaucoma Laser.
		CYCLO G6 laser for Glaucoma Dr. Nathan Radcliffe talks with EyeWorld at AAO about how MicroPulse works and how and why he treats glaucoma with the CYCLO G6 Glaucoma Laser.
		Symposium: IRIDEX MicroPulse® Technology Revolutionizes Cyclophotocoagulation In this symposium from ESCRS 2017, MicroPulse experts (Drs. Ziad Khoueir, Robert Noecker, and Marc Töteberg-Harms) discuss their experience using IRIDEX lasers and MicroPulse Technology to treat glaucoma.
		CYCLO G6 laser featured in the news WTCO Local News from Savannah, GA talked to Dr. Harris about treating glaucoma with MicroPulse Laser Trabeculoplasty and MicroPulse Cyclophotocoagulation.
		MicroPulse probe transforms transscleral cyclophotocoagulation Dr. Randy Craven tells Ophthalmology Times that MicroPulse via the CYCLO G6 Laser is demonstrating promising efficacy with better safety and tolerability than traditional TSCPC.
		Personalized Glaucoma Laser Therapy with the Titratable MicroPulse P3 Nathan Radcliffe, MD, discusses the advantages of using the MicroPulse P3 (MP3) Glaucoma Device, plus the additional benefits of providing customized cyclophotocoagulation therapy for glaucoma patients.
		Transcleral MicroPulse Laser Dynamically Alters Ciliary Muscle and Aqueous Outflow Pathways 2017 This video by Dr. Murray Johnstone provides visually controlled, real time observation of the effects of a transcleral MicroPulse 810 nm laser. The laser pulses induce shortening of the longitudinal portion of the ciliary muscle.
		Evolution in glaucoma surgery mounting with MIGS procedures An expanding armamentarium of minimally invasive and micro-invasive glaucoma surgery (MIGS) procedures, like laser treatment with the CYCLO G6 Glaucoma Laser, are transforming glaucoma management, said Steven D. Vold, MD.
		Tratamiento para glaucoma con el laser IRIDEX Cyclo G6 El Dr. Marco Antonio Beltrán, especialista en glaucoma del Centro Oftalmológico de Sonora, en Hermosillo, Mexico, habla sobre el tratamiento para el glaucoma con el láser IRIDEX Cyclo G6 con MicroPulso - una alternativa para medicamentos y cirugías.
	MicroPulse, a New Procedure Arises to Help Fight Glaucoma
	Dr. Shan Lin explains how he treats glaucoma with MicroPulse therapy

ABSTRACTS

	Selective Laser Trabeculoplasty vs Micropulse Laser Trabeculoplasty in Open-Angle Glaucoma Download Now
	Histologic Changes Following Continuous Wave And Micropulse Transscleral Cyclophotocoagulation: A Randomized Comparative Study AGS 2019 Download Now
	Transcleral Micropulse Laser (TML) Effects On Outflow System, Sclera, Ciliary Muscle (CB) & Suprachoroidal Space (SCS): Insights From High-Resolution OCT (HROCT), Real-Time Video (RTV) & Histology AGS 2019 Download Now
	Dan Yoon: Two Meta-analyses on the Outcomes of Sequential Glaucoma Drainage Implantation vs. Cyclophotocoagulation AGS 2019 Download Now
	Nadiya Kots-Gotlib: Outcomes of Ahmed Valve Implantation Supplemented with Limited Diode Cyclophotocoagulation AGS 2019 Download Now
	Beatriz Aguando: TRANSSCLERAL CYCLOPHOTOCOAGULATION WITH DIODE LASER FORREFRACTORY GLAUCOMA. OUR EXPERIENCE EGS 2018 Download Now
	Behzad Amoozgar: Comparison of Long-term Clinical Outcomes between Micropulse Transscleral Cyclophotocoagulation and Endoscopic Cyclophotocoagulation-Plus AGS 2018 Download Now
	Brett Breshears: Two-Year Retroactive Study of G6 Transscleral Cyclophotocoagulation as a Secondary Poag Treatment ASCRS 2018 Download Now
	Briana Gapsis: Analysis of the Relative Efficacy of Micropulse Laser Trabeculoplasty and Selective Laser Trabeculoplasty ARVO 2018 Download Now
	Carisa Bohnak: Micropulse Transscleral Cyclophotocoagulation in the Treatment of Patients with Primarily Severe Stage Glaucoma ASCRS April 2018 Download Now
	Catherina Goenadi: EARLY OUTCOMES OF MICROPULSE DIODE TRANSSCLERAL CYCLOPHOTOTHERAPY FOR TREATMENT OF MILD TO MODERATE GLAUCOMA EGS May 2018 Download Now
	Catherine Sun: Comparison of Outcomes of Micropulse Laser Trabeculoplasty versus Selective Laser Trabeculoplasty ARVO 2018 Download Now
	Christine Nguyen: Efficacy and Safety of Micropulse Transscleral Diode Laser Cyclophotocoagulation in the Treatment of Refractory Glaucoma ASCRS 2018 Download Now
	Cigdem Altan: EARLY CLINICAL OUTCOMES OF MICROPULSED TRANSCLERALCYCLOPHOTOCOAGULATION IN OPEN ANGLE GLAUCOMA EGS 2018 Download Now
	Dan Nguyen: Micropulse Transscleral Cyclophotocoagulation as a Primary Intervention in Primary Open-Angle Glaucoma Patients ASCRS 2018 Download Now
	Ihab Ibrahim: No More Blades, Scars or Scares: A One Year Experience of Micropulse Trans-scleral Cyclophotocoagulation from Middle East WOC 2018 Download Now
	Kareem Moussa: Histologic changes following continuous and micropulse transscleral cyclophotocoagulation: a comparative study AGS 2018 Download Now
	Karim Ghazal: Early Result of Micro Pulse Cyclophotocoagulation in Glauacoma Cases Resistant to Medication WOC June 2018 Download Now
	Krishna Patel: Effects of Micropulse Transscleral Cyclodiode Laser on Secondary Open-Angle Glaucoma ASRCS 2018 Download Now
	Leonard Seibold: Trans-scleral Cyclophotocoagulation: A Tale of Two Probes ARVO 2018 Download Now
	Marisse Masis: Pupillary mydriasis and recovery after transscleral micropulse cyclophotocoagulation AGS 2018 Download Now
	Murray Johnstone: Transcleral laser, ciliary muscle shortening & outflow pathway reorganization ARVO June 2017 Download Now
	Nadiya Kots-Gotlib: Outcomes of Ahmed Valve Implantation Supplemented with Limited Diode Cyclophotocoagulation AGS 2019 Download Now
	Phornrak Sriphon: EFFICACY OF MICROPULSE TRANSCLERAL CYCLOPHOTOCOAGULATION IN UNCONTROLLED GLAUCOMA AT SRINAGARIND HOSPITAL,THAILAND WGC 2017 Download Now
	Robert Dionisio: MLT vs SLT in the Hispanic and African American Population for Treatment of Open-Angle Glaucoma ARVO 2018 Download Now
	Satar Baghrizabehi: MICROPULSE YELLOW LASER TRABECULOPLASTY WGC 2017 Download Now
	Shotaro Asano: IOP Reduction and Morphological Changes of Ciliary Body by Micropulse Transscleral Cyclophotocoagulation WOC June 2018 Download Now
	Ted Deng: MLT (Micropulse Laser Trabeculoplasty) or Not? AGS 2018 Download Now
	Walid Zbiba: MICROPULSED TRANSCLERAL CYCLOPHOTOCOAGULATION IN GLAUCOMAMANAGEMENT: THE TUNISIAN EXPERIENCE EGS 2018 Download Now

CASE EXAMPLES

The Case of the Creeping Paracentral Visual Field Defect
What are options when a patient and her family prefer to avoid surgery?
April 2020 - Glaucoma Today
By Austin Bell, MD; Sylvia Groth, MD; Regine Pappas, MD; and Steven R. Sarkisian Jr, MD

Case Files: A Case of Iridocorneal Endothelial Syndrome
Treatment after persistent high IOP
March 2020 - Glaucoma Physician
By Matthew Rouse, MD

NEWS

• IRIDEX Launches Revised MicroPulse P3® Device for Glaucoma
• Outcome of MicroPulse Transscleral Photocoagulation in different Types of Glaucoma
• MicroPulse Trans-scleral Laser Therapy for Glaucoma
• MicroPulse® Transscleral Laser Therapy Will be Discussed in Various Presentations at ESCRS 2019
• MicroPulse cyclophotocoagulation effective in keratoplasty eyes
• Avoiding issues from inflow procedures
• Subthreshold Laser shows favorable foveal remodeling after macular hole closure
• Cook County Health presents Glaucoma Studies at ARVO
• Standardizing techniques for MicroPulse cyclophotocoagulation needed
• Study Shows MicroPulse Laser controls IOP after Keratoplasty
• MicroPulse Laser featured in several Glaucoma and Retina research presentations at two conferences
• MicroPulse TSCPC featured in multiple abstracts, posters and presentations at WGC
• IRIDEX Cyclo G6 Laser System for Glaucoma Treatment Used In Majority of Top U.S. Ophthalmology Hospitals
• Innovations with Ed Begley Jr., features IRIDEX in an upcoming episode scheduled to air on CNBC
• IRIDEX Reaches Milestone of 1000th Cyclo G6 System Shipped
• IRIDEX Announces Approval of CYCLO G6™ Glaucoma Laser System in Korea
• IRIDEX Announces Multiple Studies of MicroPulse® Laser Therapy Published at World Ophthalmology Congress
• IRIDEX Announces Dramatic Increase In MicroPulse Visibility at the 2018 ARVO Meeting
• Iridex Receives CE Mark for Transilluminated Probe

FREQUENTLY ASKED QUESTIONS

How can I order the MicroPulse P3 Device?

The MicroPulse P3 Device comes in a box of six. To place an order, speak with your local sales rep or distributor, or contact customer service at 650.962.8100 or customerservice@iridex.com.

What is the CPT code?

CPT code for cyclophotocoagulation is 66710

What is the shelf life of MicroPulse P3, G-Probe, and G-Probe Illuminate?

3 years

Can the MicroPulse P3 Device be reused?

No. The MicroPulse P3 Device is Indicated for single-use

What is MicroPulse® Technology?

MicroPulse technology is a tissue-sparing solution where a continuous-wave laser beam is chopped into a train of tiny, repetitive, low energy pulses separated by a brief rest period which allows tissue to cool between laser pulses.

RESOURCES

• MicroPulse P3 Brochure
• MicroPulse TLT Surgical Guide
• Summary of 20 peer-reviewed studies
• MicroPulse Bibliography
• Cyclo G6 Laser Manual
• MicroPulse TLT: Medicare Reimbursement
• MicroPulse TLT: Reimbursement FAQ

Photos

TRAINING

MICROPULSE TLT DURING COVID-19

As the COVID-19 pandemic continues, our thoughts go out to those who have been impacted. Our priority at IRIDEX is to support our customers, their patients and our employees. Over the past few months, ophthalmologists from around the world have been exchanging ideas and strategies to adapt to new social distancing guidelines, infection control measures, and treatment options to best manage their patients. During this time of uncertainty, many of our customers have shared with us how MicroPulse Transscleral Laser Therapy (TLT) remains a beneficial therapy for a variety of reasons. MicroPulse TLT:

• is non-incisional, safe, and effective
• can be performed in the office
• takes less than 5 minutes to performed
• entails minimal follow-up
• leaves future treatment options open
• can be applied for a wide range of glaucoma types and severity
• typically allows patients to return to normal activities within 24 hours
• uses the Cyclo-G6 laser console that can be disinfected easily
• uses a sterile, single-use, MicroPulse P3 fiber-optic delivery device

In a webinar titled “How I Am Treating Glaucoma During the COVID-19 Pandemic,” Dr. Jason Bacharach of California discussed how the current COVID-19 pandemic has changed the way clinicians treat and manage glaucoma. “Most patients presenting for urgent care usually require stronger IOP control, so I have turned to MicroPulse TLT to bridge this gap and I treat them in the office. This is a great tool for right now,” he said.

In a different webinar, Dr. Rajen Desai of New Jersey said: “Patients did not feel comfortable having to come back to the office for multiple post-op visits if I proposed incisional glaucoma surgery, so I realized I needed something dependable, predictable, safer, and low risk during this time. MicroPulse is playing a particular stronghold now that patients are averse to getting things done in general. They prioritize safety above all else, and that’s where MicroPulse shines because I tell them there is a very low risk of endophthalmitis.”

In a webinar about the evolution and versatility of MicroPulse TLT, Dr. Marc Toeteberg-Harms of Switzerland said: “My elderly patients were scared to be seen in the hospital. MicroPulse TLT enabled me to be able to treat in the office immediately thus avoiding a second consultation. Plus, post-op complications are low and this minimizes post-op visits. The outside of the laser machine and the footswitch are easy to clean.”

Dr. Branda Alegría of Guadalajara, Mexico contacted us via instagram to share a few photos and she told us the following: “MicroPulse Transscleral Laser Therapy is my best ally during the COVID-19 pandemic when facing challenging glaucoma cases.”

We are here to help you. We are thankful and honored to be supporting hundreds of ophthalmologists and patients during this dificult time. As we go forward together, please know that we value your questions, ideas and feedback. If there is something in particular that you need, please email us at glaucoma@iridex.com or contact your IRIDEX representative. Stay safe and healthy.

REVIEWS

"The revised MicroPulse P3 Device is intuitive and easy to use. The design delivers energy in a much more consistent fashion and allows for very stable contact on the sclera.”

Brian A. Francis, MD, MS
Doheny Eye Institute, UCLA

“I was using the Cyclo G6 glaucoma laser for refractory glaucoma patients, but as I saw the results and how comfortable the patients were, I started to expand its use, and now I use it for various types of glaucoma cases.”

Sandra Fernando Sieminski, MD
Ross Eye Institute, Buffalo, NY USA

"When treating patients with glaucoma, my number one goal is to prevent blindness and my number two goal is to prevent incisional glaucoma surgery, and MicroPulse Therapy can help me to achieve both.”

Nathan Radcliffe, MD
New York Eye Surgery Center

“The technique for performing MicroPulse TLT for glaucoma was already great in the past. The minimal tissue damage is a major advantage of MicroPulse TLT over standard cyclophotocoagulation in my opinion. Iridex has done a great job improving the MicroPulse P3 Device. The ergonomic enhancements made to the design of the MicroPulse P3 Device now allows a smoother movement during treatment. I feel much more comfortable, and this is resulting in an even safer and more stable treatment for glaucoma.”

Marc Toeteberg-Harms, MD, FEBO
Zurich, Switzerland

“I have performed over a hundred MicroPulse TLTs, and have not experienced a single case of iritis or CME. MicroPulse TLT is safe, effective, and can be done in the office and OR in less than 5 minutes. For surgeons who may not feel comfortable adopting the newest MIGS devices but want something effective and safe to reduce IOP with the simplest learning curve, MicroPulse TLT is an outstanding option.”

Rajan Desai, MD, FACS
East Brunswick, NJ

“Numerous published studies and clinical experience in the US, Europe and Asia over the last several years have demonstrated that it is a safe and effective option to decrease both IOP and the number of topical medications necessary in many glaucoma patients. I regularly treat a wide variety of glaucoma patients with it, and my patients are very happy with the results.”

Ahad Mahootchi, MD
The Eye Clinic of Florida, Zephyrhills, FL USA

“MicroPulse TLT has become an irreplaceable tool in my daily practice. It has allowed me to better individualize the care of my glaucoma patients, minimizing risks and allowing for clinical success even in challenging scenarios where I used to have none or few and risky treatment options. It is an evolving technology, and as we continue to learn more about it, we will unveil its full potential.”

Tomas M. Grippo, MD
Grippo Glaucoma Center, Buenos Aires, Argentina

“Since 2016, I have loved having MicroPulse TLT in my surgical toolbox for many types of glaucoma, including those in late stage and refractory stages. I am a big fan because this can often save someone from incisional surgery. Of course, selecting the right patient is key to ensure good outcomes and minimal side effects.”

Monisha Vora, MD
Wills Eye Hospital

“In a study that I performed with 71 eyes of 68 patients, I found that MicroPulse TLT demonstrated good efficacy and safety profiles with minimal vision-threatening complications in treating a variety of glaucoma types.”

Ahmed Al Habash, MD
Imam Abdulrahman Bin Faisal University, Saudi Arabia

“The MicroPulse P3 Device has become an essential part of my armamentarium for use in glaucoma surgical procedures. It provides a very safe and efficacious solution for IOP control. I have used MicroPulse P3 for some of my most complicated cases but also I feel comfortable enough using it for patients with earlier disease in which we want to avoid a filtering bleb or the placement of hardware in the eye.”

Robert Noecker, MD, MBA
Ophthalmic Consultants of Connecticut, Fairfield, CT USA

“MicroPulso laser therapy helps our patients by significantly reducing intraocular pressure without the need for invasive surgeries. We are very happy with the results.”

Vanessa Liberato, MD
Santo Domingo, Republica Dominicana

“I have been using MicroPulse TLT in my practice for more than 2 years. MicroPulse mode has proven to be an efficacious choice for many of my glaucoma patients, with significant reduction in pressure and medication use for most. I have found that after MicroPulse TLT procedures, my patients experience less pain and less post-procedural inflammation than after traditional CPC.”

Jonathan S. Myers, MD
Wills Eye Hospital

“The MicroPulse P3 Device has given me over 30% IOP lowering. With patients that are non-compliant with their medication, or we are really trying to keep off their medication, the MicroPulse P3 device allows me to treat patients more aggressively.”

Steven Vold, MD
Vold Vision, Fayetteville, AR USA

“MicroPulse Transscleral Laser Therapy is my best ally during the COVID-19 pandemic when facing challenging glaucoma cases. I have been using MicroPulse TLT with the Cyclo G6 Laser to treat glaucoma for nearly two years and my outcomes have been excellent so far.”

Branda Alegría, MD
Guadalajara, Mexico

“I have been impressed that the MicroPulse therapy can deliver pressure lowering in a broad range of glaucomas, including mild and moderate patients who I want to free from the adverse effects of drops.”

Rolando Toyos, MD
Toyos Clinic, Nashville, TN USA

“I have found the MicroPulse P3 Device to be a non-incisional, easy, and safe way to reduce pressure anytime my patients need it, and it is predictable and highly efficacious.”

Melissa Toyos, MD
Toyos Clinic, Nashville, TN USA

“Today we treated 8 patients, and we saw considerable reductions in IOP in all of them. Plus, we avoided the need for a valve in two of the patients.”

Gustavo Aviles, MD, PhD
Lima, Peru

“In my practice, the addition of MicroPulse TLT has proven to be a safe, effective and reliable approach for lowering IOP. Personally, I have used MicroPulse TLT on patients with mild to wild glaucoma – and for good reason. It is safe and effective without yielding major impact on the target tissue, and it’s repeatable if necessary.”

Nir Shoham-Hazon, MD
Miramichi, Canada

“I have been using MicroPulse TLT to treat glaucoma for the past few months. The outcomes have been positive. I particularly use it in patients with cataract and glaucoma to reduce or eliminate their dependency on medications.”

José Antonio Bermudez Magner, MD
Mexico City, Mexico

“MicroPulse TLT shows promise for surgeons who wish to avoid further invasive procedures. It also works well in tandem with tube shunt implants before primary implantation. Overall, the procedure is straightforward and fast, with easy recovery and minimal complication rates.”

Brian M. Jerkins, MD
Hamilton Eye Institute, Memphis, TN USA

“It is important to have many choices in managing chronic diseases like glaucoma. Because MicroPulse laser is non-incisional and repeatable, it keeps all other options open.”

Makoto Aihara MD, PhD
University of Tokyo, Japan

“MicroPulse P3 is very effective in the treatment of late stage glaucoma. Early clinical data suggest it may also be an effective treatment to reduce IOP in mild to moderate glaucoma.”

Maria Cecilia Aquino, MD
National University Hospital Singapore

“MicroPulse P3 for glaucoma has improved my ability to treat more patients with a repeatable procedure.”

Poemen Chan, MD
The Chinese University of Hong Kong

MANUAL & IFU

MicroPulse P3® Device

• Instructions for Use

Cyclo G6® Laser

• Manual - Dutch
• Manual - English
• Manual - Finnish
• Manual - French
• Manual - German
• Manual - Italian
• Manual - Portuguese
• Manual - Spanish

REIMBURSEMENT

ORDERING

To order the MicroPulse P3 Delivery Device, speak with your local sales representative, distributor, email us at customerservice@iridex.com, or call us at +1.650.962.8100

• The part number is 15522
• Six probes are included in a box
• The MicroPulse P3 Device is a single-use device